Integrative multi-omics analysis of muscle-invasive bladder cancer identifies prognostic biomarkers for frontline chemotherapy and immunotherapy
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Integrative multi-omics analysis of muscle-invasive bladder cancer identifies prognostic biomarkers for frontline chemotherapy and immunotherapy
Authors
Keywords
-
Journal
Communications Biology
Volume 3, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-12-17
DOI
10.1038/s42003-020-01491-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysis
- (2020) Ann Taber et al. Nature Communications
- Tipping the immunostimulatory and inhibitory DAMP balance to harness immunogenic cell death
- (2020) K. Hayashi et al. Nature Communications
- Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma
- (2019) Yohann Loriot et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Consensus Molecular Classification of Muscle-invasive Bladder Cancer
- (2019) Aurélie Kamoun et al. EUROPEAN UROLOGY
- PL1.1 CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDHmutant gliomas
- (2019) R Appay et al. NEURO-ONCOLOGY
- Statistical genomics in rare cancer
- (2019) Farnoosh Abbas-Aghababazadeh et al. SEMINARS IN CANCER BIOLOGY
- Prognostic Power of a Tumor Differentiation Gene Signature for Bladder Urothelial Carcinomas
- (2018) Qianxing Mo et al. JNCI-Journal of the National Cancer Institute
- Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial
- (2018) Thomas Powles et al. LANCET
- Prognostic Power of a Tumor Differentiation Gene Signature for Bladder Urothelial Carcinomas
- (2018) Qianxing Mo et al. JNCI-Journal of the National Cancer Institute
- Molecular Subtypes of Urothelial Bladder Cancer: Results from a Meta-cohort Analysis of 2411 Tumors
- (2018) Tuan Zea Tan et al. EUROPEAN UROLOGY
- TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
- (2018) Sanjeev Mariathasan et al. NATURE
- Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy
- (2017) Roland Seiler et al. EUROPEAN UROLOGY
- Evaluation of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Kinase Inhibitor, in Patients With Advanced Solid Tumors Harboring Genetic Alterations in Fibroblast Growth Factor Receptors: Results of a Global Phase I, Dose-Escalation and Dose-Expansion Study
- (2017) Lucia Nogova et al. JOURNAL OF CLINICAL ONCOLOGY
- Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial
- (2017) Arjun V Balar et al. LANCET
- Oncogenic Characterization and Pharmacologic Sensitivity of Activating Fibroblast Growth Factor Receptor (FGFR) Genetic Alterations to the Selective FGFR Inhibitor Erdafitinib
- (2017) Jayaprakash D. Karkera et al. MOLECULAR CANCER THERAPEUTICS
- Precision medicine for urothelial bladder cancer: update on tumour genomics and immunotherapy
- (2017) Kenneth M. Felsenstein et al. Nature Reviews Urology
- Role of CDKN2A/p16 expression in the prognostication of oral squamous cell carcinoma
- (2017) Swati Shree Padhi et al. ORAL ONCOLOGY
- Novel therapeutic targets in advanced urothelial carcinoma
- (2016) Mathieu Rouanne et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- A Prognostic Gene Expression Signature in the Molecular Classification of Chemotherapy-naïve Urothelial Cancer is Predictive of Clinical Outcomes from Neoadjuvant Chemotherapy: A Phase 2 Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin with Bevacizumab in Urothelial Cancer
- (2016) David J. McConkey et al. EUROPEAN UROLOGY
- Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy
- (2016) Christina Pfirschke et al. IMMUNITY
- Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
- (2016) Jonathan E Rosenberg et al. LANCET
- Molecular analysis of urothelial cancer cell lines for modeling tumor biology and drug response
- (2016) M L Nickerson et al. ONCOGENE
- Invasive Bladder Cancer: Genomic Insights and Therapeutic Promise
- (2015) J. Kim et al. CLINICAL CANCER RESEARCH
- Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy
- (2014) Woonyoung Choi et al. CANCER CELL
- Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance
- (2014) Antonina V. Kurtova et al. NATURE
- MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
- (2014) Thomas Powles et al. NATURE
- International progress: from cytology to genomics
- (2014) James C. Costello et al. Nature Reviews Urology
- Copy Number Loss of the Interferon Gene Cluster in Melanomas Is Linked to Reduced T Cell Infiltrate and Poor Patient Prognosis
- (2014) Peter S. Linsley et al. PLoS One
- Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology
- (2014) J. S. Damrauer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype
- (2014) S. Rebouissou et al. Science Translational Medicine
- Sparse integrative clustering of multiple omics data sets
- (2013) Ronglai Shen et al. Annals of Applied Statistics
- Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
- (2013) Gabriela Bindea et al. IMMUNITY
- Pattern discovery and cancer gene identification in integrated cancer genomic data
- (2013) Qianxing Mo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Stat3 Activation in Urothelial Stem Cells Leads to Direct Progression to Invasive Bladder Cancer
- (2012) P. L. Ho et al. CANCER RESEARCH
- Combination of a Novel Gene Expression Signature with a Clinical Nomogram Improves the Prediction of Survival in High-Risk Bladder Cancer
- (2012) Markus Riester et al. CLINICAL CANCER RESEARCH
- A Molecular Taxonomy for Urothelial Carcinoma
- (2012) G. Sjodahl et al. CLINICAL CANCER RESEARCH
- Phase II Trial of Cetuximab With or Without Paclitaxel in Patients With Advanced Urothelial Tract Carcinoma
- (2012) Yu-Ning Wong et al. JOURNAL OF CLINICAL ONCOLOGY
- CDKN2A homozygous deletion is associated with muscle invasion in FGFR3-mutated urothelial bladder carcinoma
- (2012) Sandra Rebouissou et al. JOURNAL OF PATHOLOGY
- Normal and neoplastic urothelial stem cells: getting to the root of the problem
- (2012) Philip Levy Ho et al. Nature Reviews Urology
- Three differentiation states risk-stratify bladder cancer into distinct subtypes
- (2012) J.-P. Volkmer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting tumors that lack methylthioadenosine phosphorylase (MTAP) activity
- (2011) Joseph R. Bertino et al. CANCER BIOLOGY & THERAPY
- A phase II trial of neoadjuvant erlotinib in patients with muscle-invasive bladder cancer undergoing radical cystectomy: clinical and pathological results
- (2010) Raj S. Pruthi et al. BJU INTERNATIONAL
- Preoperative CTLA-4 Blockade: Tolerability and Immune Monitoring in the Setting of a Presurgical Clinical Trial
- (2010) B. C. Carthon et al. CLINICAL CANCER RESEARCH
- Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancer
- (2010) Wun-Jae Kim et al. Molecular Cancer
- Integrative clustering of multiple genomic data types using a joint latent variable model with application to breast and lung cancer subtype analysis
- (2009) Ronglai Shen et al. BIOINFORMATICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started